WFA
FOLD

Wipfli Financial Advisors’s Amicus Therapeutics FOLD Stock Holding History

Wipfli Financial Advisors’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$4K Buy
+358
New +$3.99K ﹤0.01% 2135

Other funds holding FOLD

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Wipfli Financial Advisors's FOLD Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Amicus Therapeutics (FOLD) in Q3 2022: 358 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #2135 among its holdings.

222 funds tracked by Wall St. Rank hold FOLD as of Q3 2022.

  • Wipfli Financial Advisors held 358 shares of Amicus Therapeutics worth $4K as of Q3 2022.
  • Amicus Therapeutics was a new Wipfli Financial Advisors position in Q3 2022.
  • Amicus Therapeutics made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #2135 holding.
  • 222 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.